These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17650609)

  • 21. [Creation of collateral circulation in the internal membranes of the eye].
    Voloshinov DB
    Vestn Oftalmol; 1971; 4():44-8. PubMed ID: 5143609
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic viewpoints in disorders of the terminal vascular bed].
    Ehrly AM
    Med Welt; 1974 Jul; 25(27-28):1221-4. PubMed ID: 4471937
    [No Abstract]   [Full Text] [Related]  

  • 23. [Aging processes and the eye].
    Kashintseva LT
    Oftalmol Zh; 1980; 35(7):387-91. PubMed ID: 7010250
    [No Abstract]   [Full Text] [Related]  

  • 24. An attempted synopsis of the physiology and pathology of the systemic and ocular arterial system.
    Thiel R
    S Afr Med J; 1966 Sep; 40(33):777-83. PubMed ID: 5920619
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of vasospasm on visual function.
    Gasser P; Flammer J
    Doc Ophthalmol; 1987 May; 66(1):3-18. PubMed ID: 3322745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current perspectives on venous disease.
    Myers DD
    Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):839-41. PubMed ID: 22908916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Place of macromolecular preparations in ophthalmological therapy].
    Fodor F; Sireteanu L; Csiszár A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1978; 27(2):123-5. PubMed ID: 674721
    [No Abstract]   [Full Text] [Related]  

  • 28. [New therapeutical perspectives in ophthalmology].
    Riu R; Darleguy P; Gacon R
    Therapeutique; 1970 Nov; 46(9):925-8. PubMed ID: 5486143
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ultrastructural aspects of the action of a phlebotropic drug].
    Martines G; Antonioli GE; Musacci GF
    Minerva Cardioangiol; 1972 Oct; 20(10):582-97. PubMed ID: 5080092
    [No Abstract]   [Full Text] [Related]  

  • 30. O-(beta-hydroxyethyl)-rutosides (Paroven; Venoruton): new studies, improved safety, and novel cardiovascular applications.
    Cesarone MR; Belcaro G; Grossi MG
    Angiology; 2008; 59 Suppl 1():5S-6S. PubMed ID: 18287161
    [No Abstract]   [Full Text] [Related]  

  • 31. [Problems in the treatment of ocular circulatory disturbances (author's transl)].
    Hager H
    Klin Monbl Augenheilkd; 1974 Jul; 165(1):127-36. PubMed ID: 4471873
    [No Abstract]   [Full Text] [Related]  

  • 32. [Eye lesions in cardiovascular pathology].
    Rudinskaia GM
    Med Sestra; 1980 Dec; 39(12):3-6. PubMed ID: 6906581
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and experimental study of the action of triethylene-thiophosphoramide on corneal vascularization].
    Lavergne G
    Bull Mem Soc Fr Ophtalmol; 1967; 80():146-55. PubMed ID: 4998888
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of ocular symptoms in myasthenia gravis.
    Bhanushali MJ; Wuu J; Benatar M
    Neurology; 2008 Oct; 71(17):1335-41. PubMed ID: 18936425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in drug delivery systems for treating ocular complications of systemic diseases.
    Lee SS; Hughes PM; Robinson MR
    Curr Opin Ophthalmol; 2009 Nov; 20(6):511-9. PubMed ID: 19667987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chapter 6. Ocular models of angiogenesis.
    Aguilar E; Dorrell MI; Friedlander D; Jacobson RA; Johnson A; Marchetti V; Moreno SK; Ritter MR; Friedlander M
    Methods Enzymol; 2008; 444():115-58. PubMed ID: 19007663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of disorders in the autoregulation of the intraocular blood circulation in the development of dystrophic changes in eye tissues].
    Kornilovskiĭ IM
    Oftalmol Zh; 1982; 37(8):477-80. PubMed ID: 7162741
    [No Abstract]   [Full Text] [Related]  

  • 38. L-carnitine and its derivatives: a promising future in the treatment of ocular disorders.
    Feher J
    Drugs R D; 2008; 9 Suppl 1():33-4. PubMed ID: 19105590
    [No Abstract]   [Full Text] [Related]  

  • 39. The impact of novel treatment modalities on the therapeutic approach of cardiovascular diseases.
    Paraskevas KI; Psathas C; Dragios T; Chatzis DG; Mikhailidis DP; Kyriakides ZS
    Angiology; 2009; 60(1):5-7. PubMed ID: 19190028
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of research in the field of vascular eye pathology].
    Trutneva KV; Shul'pina NB
    Vestn Oftalmol; 1977; (5):48-53. PubMed ID: 906207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.